15 May 2024
Catherine Jamieson
[FYI request #23680 email]
Tēnā koe Catherine
Your request for official information, reference: HNZ00043798
Thank you for your emails of 30 April 2024 respectively, asking Health New Zealand | Te Whatu
Ora questions under the Of icial Information Act 1982 (the Act).
Received 8 April 2024
Please provide reference to the section/part of the Official Information Act under which my
request is being denied.
Under the Public Records Act shouldn't there be stored records to be retrieved and queried
to provide receiving data for these batches? Can you do that please or if not, please
provide the reason why not.
For clarity I am requiring receiving location data that was not supplied in HNZ00030152,
namely:-
1. Please include distribution data as per the original request for batches - EP2163,
EP9605, ER7449, ET3045, ET9096
2. Please include any distribution data additional to that already provided for the following
batches (or distribution data in respect of any other batches additional to those
mentioned in this request that may not have been supplied in HNZ00030152 table) to
provide a complete response to the initial request. EX2405, FA5833, FC3558, FC5029,
FD0927, FD9234, FE2090, FE3064, FE8163, FF2382, FF4206, FG0050, FG3716
The Medsafe product detail for the purple cap (Tozinameran 0.5 mg/mL equivalent to 30
µg/0.3mL dose) product is below.
https://www.medsafe.govt.nz/regulatory/ProductDetail.asp?ID=21938
The reply given does not make any differentiation for the composition change reflected in
this Product Detail. If the modified purple cap product was distributed within NZ please
modify the file to reflect what was asked in the original question.
'...what was(were) the date(s) any product of altered composition was imported into NZ,
and date(s) first used on consumers. By composition category please supply batch
numbers, the sites those batches were distributed to for administration and on what dates.’
Received 30 April 2024
The MoH reply of April 16 stil does not answer the question. For clarity, there was an
amendment to the product detail for the Tozinameran 30mcg product with PBS buffer
where a new excipient was available from December 2021.
https://www.medsafe.govt.nz/regulatory/ProductDetail.asp?ID=21938
Please notify which batch numbers contained the initial excipient formation and which batch
numbers contained the excipient available from December 2021.
Response
Health NZ has not been able to find any records of distribution locations for those batches
referenced in your request. We also do not hold information relating to your request for
which batch
numbers contained the initial excipient formation and which batch numbers contained the excipient
available from December 2021. The change in excipients did not impact the way that the vaccines
were handled, administered, or recorded, therefore, we do not hold information on which batch
numbers contained the initial excipient formulation and which batch numbers contained the
excipient available from December 2021.
As such, we are refusing your requests in full under section 18(g) of the Act as the information
requested is not held by us and we have no grounds to believe that it is held by another entity
subject to the Act.
How to get in touch
If you have any questions, you can contact us at
[email address].
If you are not happy with this response, you have the right to make a complaint to the
Ombudsman. Information about how to do this is available at
www.ombudsman.parliament.nz or
by phoning 0800 802 602.
Nāku iti noa, nā
Danielle Coe
Manager (OIA) Government Services
Health New Zealand | Te Whatu Ora
TeWhatuOra.govt.nz
Health NZ, PO Box 793,
Wel ington 6140, New Zealand
